Delivery Order SPE2DR25D3103-SPE2DR26F9V66
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $10,560.80 to AmerisourceBergen Drug Corp for the supply of Vemlidy 25 mg tablets (30-count units) on August 4, 2025, with an ultimate completion date of August 5, 2025. This firm fixed-price, non-set-aside contract represents a single delivery order under AmerisourceBergen's larger pharmaceutical supply agreement with DLA. The place of performance is listed as Conshohocken, Pennsylvania, where AmerisourceBergen maintains its...
- The Defense Logistics Agency awarded a delivery order valued at $4,700.52 to AmerisourceBergen Drug Corp for Vemlidy 25 mg tablets (30-count units) on July 28, 2025, with an ultimate completion date of July 29, 2025. This competitively awarded, firm fixed-price delivery order represents a non-set-aside contract for pharmaceutical supply to support federal medical procurement needs. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 18, 2025, for the supply of Vemlidy 25 mg tablets (30-count units) under a firm fixed-price contract valued at $12,049.24. This is a non-set-aside competitive award with an ultimate completion date of September 19, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC)...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $10,624.87 to AmerisourceBergen Drug Corp for Vemlidy 25 mg tablets (quantity 30) on December 19, 2025, with completion expected by December 22, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the vendor's corporate office in Conshohocken, Pennsylvania. Vemlidy is an antiviral medication used in the treatment of chronic hepatitis B, representing the...
- The Defense Logistics Agency awarded a delivery order valued at $8,114.38 to AmerisourceBergen Drug Corp for Vemlidy 25 mg tablets (30-count units) on November 7, 2025, with an ultimate completion date of November 10, 2025. This firm fixed-price delivery order represents a non-competitive award under a larger contract vehicle and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The product—Vemlidy, an antiviral medication used in hepatitis B...
- The Defense Logistics Agency awarded a delivery order valued at $8,204.95 to AmerisourceBergen Drug Corp for Vemlidy 25 mg tablets (30-count units) on December 2, 2025, with completion expected by December 3, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded to the prime contractor's corporate office located in Conshohocken, Pennsylvania. Vemlidy is a prescription antiviral medication used in hepatitis B treatment, reflecting the Defense...
- The Defense Logistics Agency awarded a $12,507.84 delivery order to AmerisourceBergen Drug Corp on January 2, 2026, for the supply of Vemlidy 25 mg tablets in quantities of 30 units. This is a firm fixed price, competitively awarded contract with an ultimate completion date of January 5, 2026, and represents a child order under a larger contract vehicle. The award carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $7,762.93 to AmerisourceBergen Drug Corp for 30-count units of Vemlidy 25 mg tablets. This is a firm fixed-price, competitively awarded contract with an ultimate completion date of December 19, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. No set-aside designation was applied to this award. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $7,066.42 for Vemlidy 25 mg tablets (30-count units) on December 22, 2025, with an ultimate completion date of December 23, 2025. This non-competitive, firm fixed-price delivery order was placed under AmerisourceBergen's broader Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.999 billion prime vendor agreement running through December 2026. The contract has no set-aside...
- The Defense Logistics Agency awarded a $12.76K delivery order to AmerisourceBergen Drug Corp on November 13, 2025, for the supply of Vemlidy 25 mg tablets in quantities of 30 units. This is a firm fixed-price, non-set-aside delivery order with an ultimate completion date of November 14, 2025, and will be performed at the contractor's location in Conshohocken, Pennsylvania. Vemlidy is an antiviral medication used in the treatment of chronic hepatitis B, representing the type of specialized...
- SPE2DR25D3103Indefinite Delivery Contract
- SPE2DR25D3103-SPE2DR26F9V66Delivery Order
On January 8, 2026, the Defense Logistics Agency awarded a delivery order valued at $18,972.34 to AmerisourceBergen Drug Corp for Vemlidy 25 mg tablets (30-count units). This firm fixed-price, non-set-aside contract is scheduled for completion by January 9, 2026, with performance at the contractor's facility in Conshohocken, Pennsylvania. The award represents a task order under AmerisourceBergen's parent company, Cencora, Inc.'s, larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2031, which serves as the primary vehicle for delivering pharmaceutical products and medical supplies to support military healthcare programs globally. This delivery order is part of routine pharmaceutical procurement operations supporting federal military healthcare systems. Vemlidy is an antiviral medication used in hepatitis B treatment, reflecting the Defense Logistics Agency's responsibility for sourcing specialized medical commodities across multiple therapeutic domains for the Department of Defense and other federal health agencies. AmerisourceBergen Drug Corp, as a major pharmaceutical distributor, has demonstrated sustained capability to fulfill federal medical supply requirements through competitive contracting and maintains an extensive portfolio of drug deliveries to military and veteran healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $19.0k | 1/7/26 |